Stra13 and Sharp-1, the Non-Grouchy Regulators of Development and Disease
- 1 January 2014
- book chapter
- Published by Elsevier
- Vol. 110, 317-338
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Accelerated cellular senescence phenotype of GAPDH-depleted human lung carcinoma cellsBiochemical and Biophysical Research Communications, 2011
- Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: Quantitative immunohistochemistry in tissue microarraysEuropean Journal of Cancer, 2011
- The rexinoid bexarotene represses cyclin D1 transcription by inducing the DEC2 transcriptional repressorBreast Cancer Research and Treatment, 2010
- Sharp‐1 modulates the cellular response to DNA damageFEBS Letters, 2009
- Requirement for the basic helix-loop-helix transcription factor Dec2 in initial TH2 lineage commitmentNature Immunology, 2009
- Regulation of cancer cell metabolism by hypoxia-inducible factor 1Seminars in Cancer Biology, 2009
- SHARP1/DEC2 inhibits adipogenic differentiation by regulating the activity of C/EBPEMBO Reports, 2008
- The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 miceBritish Journal of Cancer, 2008
- Stra13 is induced by genotoxic stress and regulates ionizing‐radiation‐induced apoptosisEMBO Reports, 2007
- MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscleProceedings of the National Academy of Sciences, 2006